ZA927779B - Osmotic drug delivery devices with hydrophobic wall materials. - Google Patents

Osmotic drug delivery devices with hydrophobic wall materials.

Info

Publication number
ZA927779B
ZA927779B ZA927779A ZA927779A ZA927779B ZA 927779 B ZA927779 B ZA 927779B ZA 927779 A ZA927779 A ZA 927779A ZA 927779 A ZA927779 A ZA 927779A ZA 927779 B ZA927779 B ZA 927779B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery devices
wall materials
osmotic drug
hydrophobic wall
Prior art date
Application number
ZA927779A
Other languages
English (en)
Inventor
Eun Soo Lee
Scott A Bura
Su Il Yum
Patrick S L Wong
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA927779B publication Critical patent/ZA927779B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
ZA927779A 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials. ZA927779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77563591A 1991-10-10 1991-10-10

Publications (1)

Publication Number Publication Date
ZA927779B true ZA927779B (en) 1993-07-05

Family

ID=25105009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927779A ZA927779B (en) 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials.

Country Status (10)

Country Link
US (1) US5795591A (pt)
EP (1) EP0607321A1 (pt)
JP (1) JPH07500264A (pt)
AU (1) AU2867492A (pt)
CA (1) CA2115648C (pt)
MX (1) MX9205850A (pt)
NZ (1) NZ244682A (pt)
PT (1) PT100944B (pt)
WO (1) WO1993006819A1 (pt)
ZA (1) ZA927779B (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022424A1 (en) * 1993-03-29 1994-10-13 Alza Corporation Biodegradable, water-permeable membrane for fluid-imbibing pump
WO1995003033A1 (en) 1993-07-22 1995-02-02 Pfizer Inc. Osmotic devices having vapor-permeable coatings
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6132420A (en) * 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US5954966A (en) * 1997-01-31 1999-09-21 University Of Ottawa Membrane composition and method of preparation
DK0969820T3 (da) * 1997-03-24 2005-04-25 Alza Corp Implanterbar udleveringsanordning med en selvjusterende udgangsport
ZA981610B (en) 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
ES2213404T3 (es) * 1998-12-17 2004-08-16 Alza Corporation Transformacion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples revestimientos.
US6491683B1 (en) * 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
CA2402637C (en) 1999-12-21 2007-04-10 Alza Corporation Valve for osmotic devices
EP1239839A2 (en) 1999-12-23 2002-09-18 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
CN1402632A (zh) * 1999-12-23 2003-03-12 辉瑞产品公司 水凝胶驱动的药物剂型
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
CA2417552C (en) 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
KR100994543B1 (ko) 2001-02-16 2010-11-16 아스텔라스세이야쿠 가부시키가이샤 Ｆｋ506을 포함하는 이식편
DK1377276T3 (da) * 2001-04-10 2012-01-02 Sun Pharma Advanced Res Co Ltd Beregning af puls-frigivelsessammensætning
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
US20030064095A1 (en) 2001-09-14 2003-04-03 Imedd, Inc. Microfabricated nanopore device for sustained release of therapeutic agent
TWI222997B (en) * 2001-12-10 2004-11-01 Ind Tech Res Inst Method for tissue culture in vitro
DE60315474T2 (de) * 2002-06-17 2008-04-24 Alza Corp., Mountain View Osmotische abgabesysteme mit osmotischen antrieb und verfahren zur herstellung sowohl des osmotischen antriebs als auch des osmotischen abgabesystems
KR101046903B1 (ko) * 2002-06-26 2011-07-06 인타르시아 세라퓨틱스 인코포레이티드 삼투성 약물 전달 시스템을 위한, 최소로 튀는 용적효율성 피스톤
US20040133270A1 (en) * 2002-07-08 2004-07-08 Axel Grandt Drug eluting stent and methods of manufacture
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP3470108A1 (en) * 2004-07-02 2019-04-17 Mati Therapeutics Inc. Treatment medium delivery device for delivery of treatment media to the eye
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
DE102004042578A1 (de) * 2004-09-02 2006-03-23 Roche Diagnostics Gmbh Mikropumpe zur Förderung von Flüssigkeiten mit niedrigen Förderraten im Druck/Saug-Betrieb
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US20080009423A1 (en) 2005-01-31 2008-01-10 Halliburton Energy Services, Inc. Self-degrading fibers and associated methods of use and manufacture
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US8801694B2 (en) * 2005-08-11 2014-08-12 Massachusetts Institute Of Technology Intravesical drug delivery device
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
ES2422864T3 (es) 2006-08-09 2013-09-16 Intarcia Therapeutics, Inc Sistemas de liberación osmótica y unidades de pistón
CA2671092A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
PT2157967E (pt) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
BRPI0820800B8 (pt) 2007-12-11 2021-06-22 Massachusetts Inst Technology dispositivo médico implantável para liberação controlada de droga
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
JP5908279B2 (ja) * 2008-08-09 2016-04-26 マサチューセッツ インスチテュート オブ テクノロジーＭａｓｓａｃｈｕｓｅｔｔｓ Ｉｎｓｔｉｔｕｔｅ Ｏｆ Ｔｅｃｈｎｏｌｏｇｙ 移植可能な薬物送達デバイス並びに男性の尿生殖器及び周囲組織を治療する方法
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
JP5854513B2 (ja) 2009-08-03 2016-02-09 インキューブ ラブズ， エルエルシー 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
KR101823699B1 (ko) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
PT2512581T (pt) * 2009-12-17 2021-04-27 Taris Biomedical Inc Dispositivo implantável com tolerabilidade intravesical e métodos de tratamento
US8759284B2 (en) * 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) * 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
ES2943334T3 (es) 2011-01-10 2023-06-12 Taris Biomedical Llc Régimen de lidocaína para el uso de tratamiento sostenido del dolor de vejiga y micción irritativa
BR112013019410A2 (pt) 2011-02-04 2019-09-24 Taris Biomedical Inc dispositivo implantável para liberação controlada de fármaco de solubilidade baixa
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
KR102398262B1 (ko) 2013-03-15 2022-05-13 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법
EP3736015B1 (en) 2013-08-19 2023-06-28 TARIS Biomedical LLC Multi-unit drug delivery devices
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
US10143804B2 (en) 2015-05-29 2018-12-04 ZebraSci, Inc Biopolymer-based emulsion lubricants for syringe barrels
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US20190298771A1 (en) 2016-09-28 2019-10-03 Atossa Genetics Inc. Methods of adoptive cell therapy
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991766A (en) * 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4142526A (en) * 1974-12-23 1979-03-06 Alza Corporation Osmotic releasing system with means for changing release therefrom
US4034758A (en) * 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4220153A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4400374A (en) * 1979-06-22 1983-08-23 Environmental Chemicals, Inc. Controlled release of compounds utilizing a plastic matrix
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4552752A (en) * 1983-01-31 1985-11-12 Rohm And Haas Company Microbiocidal article for aqueous systems
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4656057A (en) * 1983-07-28 1987-04-07 Rohm And Haas Company Microbiocidal article for aqueous systems
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US5145945A (en) * 1987-12-17 1992-09-08 Allied-Signal Inc. Homopolymers and copolymers having recurring carbonate units
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5223266A (en) * 1990-01-24 1993-06-29 Alza Corporation Long-term delivery device with early startup

Also Published As

Publication number Publication date
US5795591A (en) 1998-08-18
WO1993006819A1 (en) 1993-04-15
CA2115648C (en) 2002-04-09
PT100944B (pt) 2000-02-29
EP0607321A1 (en) 1994-07-27
CA2115648A1 (en) 1993-04-15
PT100944A (pt) 1994-06-30
JPH07500264A (ja) 1995-01-12
MX9205850A (es) 1993-06-01
NZ244682A (en) 1993-12-23
AU2867492A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
ZA927779B (en) Osmotic drug delivery devices with hydrophobic wall materials.
US5525634B1 (en) Colonic drug delivery system
GR3018890T3 (en) Medicament dispensing device.
EP0670716A4 (en) TASTE-MASKED PHARMACEUTICAL SUBSTANCES.
ZA926020B (en) Pharmaceutical combination formulation.
AU2937892A (en) Polymer-based osmotic drug delivery system
IL109661A0 (en) Drug delivery device
EP0662851A4 (en) DRUG DELIVERY SYSTEM.
GR3036937T3 (en) Pharmaceutical formulations.
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
ZA927562B (en) Medicament.
ZA936620B (en) Medicament dispensing device.
EP0523943A3 (en) Pharmaceutical container
GB9117717D0 (en) Dispenser pumps
EP0523942A3 (en) Pharmaceutical container
GB9021094D0 (en) Liquid delivery systems
EP0613445A4 (en) DISTRIBUTOR.
ZA929294B (en) Syringe.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
ZA927506B (en) New drug formulation.
GB9109021D0 (en) Dosing pump
ZA929724B (en) Ballisitc materials.
GB9104226D0 (en) Liquid delivery system
EP0600754A3 (en) Continuous flow pharmaceutical transfusion.
EP0641193A4 (en) CHEMOTHERAPEUTIC DRUG COMBINATIONS.